| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.544 | 15.954 | 51.931 | 82.965 | 101.024 | 169.825 |
| Total Income - EUR | - | - | - | - | 2.544 | 15.954 | 51.931 | 83.939 | 101.663 | 169.933 |
| Total Expenses - EUR | - | - | - | - | 1.925 | 12.667 | 23.874 | 28.070 | 43.016 | 46.099 |
| Gross Profit/Loss - EUR | - | - | - | - | 619 | 3.287 | 28.057 | 55.869 | 58.647 | 123.833 |
| Net Profit/Loss - EUR | - | - | - | - | 543 | 2.838 | 26.686 | 54.038 | 57.788 | 119.502 |
| Employees | - | - | - | - | 0 | 0 | 0 | 2 | 2 | 3 |
Check the financial reports for the company - Cardiaqmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 54.556 | 43.684 | 36.510 | 27.301 | 66.050 |
| Current Assets | - | - | - | - | 2.115 | 4.448 | 24.468 | 74.035 | 131.231 | 202.848 |
| Inventories | - | - | - | - | 0 | 0 | 103 | 1.137 | 1.373 | 14.270 |
| Receivables | - | - | - | - | 1.736 | 2.148 | 2.720 | 7.399 | 4.802 | 8.751 |
| Cash | - | - | - | - | 379 | 2.299 | 21.645 | 65.499 | 125.057 | 179.827 |
| Shareholders Funds | - | - | - | - | 585 | 3.453 | 30.062 | 84.193 | 141.726 | 259.151 |
| Social Capital | - | - | - | - | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | 1.530 | 55.551 | 38.089 | 26.352 | 16.806 | 9.747 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardiaqmed S.r.l.